Suchergebnisse - "Tamura, Tomohide"

PubPharm (224)

1

A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer

enthalten in: Cancer chemotherapy and pharmacology | 2009

von Yamamoto, N. | Tamura, T. | Kurata, T. | +5

2

A phase II study of cisplatin and irinotecan as induction chemotherapy followed by accelerated hyperfractionated thoracic radiotherapy with daily low-dose carboplatin in unresectable stage III non-small cell lung cancer : JCOG 9510

enthalten in: Japanese journal of clinical oncology | 2009

von Fujii, T. | Kunikane, H. | Okamoto, H. | +7

3

Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2009

von Yamamoto, N. | Tamura, T. | Yamamoto, N. | +10

4

Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy

enthalten in: Japanese journal of clinical oncology | 2009

von Sekine, I. | Sumi, M. | Ito, Y. | +6

5

Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients

enthalten in: Cancer chemotherapy and pharmacology | 2009

von Sai, K. | Saito, Y. | Maekawa, K. | +16

6

Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients

enthalten in: Cancer chemotherapy and pharmacology | 2009

von Sai, K. | Saito, Y. | Maekawa, K. | +16

7

Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients

enthalten in: Cancer chemotherapy and pharmacology | 2009

von Sai, K. | Saito, Y. | Maekawa, K. | +16

8

mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells

enthalten in: Cancer research | 2009

von Matsumoto, K. | Arao, T. | Tanaka, K. | +9

9

Phase I and pharmacokinetic study of vorinostat (suberoylanilide hydroxamic acid) in Japanese patients with solid tumors

enthalten in: Cancer science | 2009

von Fujiwara, Y. | Yamamoto, N. | Yamada, Y. | +6

10

Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2009

von Sekine, I. | Nokihara, H. | Yamamoto, N. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]